Market Place
Sourcing Support
Rapid Dose Therapeutics Reports Fiscal Year 2023 Financial Results
28 Jun 2023 //
BUSINESSWIRE
Rapid Dose Announces Proposed Private Placement Financing
02 Jun 2023 //
BUSINESSWIRE
Rapid Dose Announces Change of Auditor
17 May 2023 //
BUSINESSWIRE
Rapid Dose Announces Board of Director Changes
14 Apr 2023 //
BUSINESSWIRE
Rapid Dose Announces Filing of Corrective Disclosure
14 Apr 2023 //
BUSINESSWIRE
Rapid Dose Therapeutics Reports Quarterly Financial Results
01 Feb 2023 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
10 Jan 2023 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
29 Dec 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
20 Dec 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
12 Dec 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
29 Nov 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
21 Nov 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
07 Nov 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
24 Oct 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics to Participate in the Venture Mentoring Services Program
29 Sep 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Enters Supplier and Purchase Agreement
23 Sep 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
12 Sep 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Confirms Delay in Filing Annual Financial Statements
29 Aug 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update
25 Aug 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update
11 Aug 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update
13 Jul 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Announces Issuance of Management Cease Trade Order
30 Jun 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Announces Delay in Filing Annual Financial Statements
16 Jun 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Corp Announces Proposed Private Placement
26 May 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Closes First Tranche of Private Placement
25 May 2022 //
BUSINESSWIRE
RDT inks deals to push oral film tech to COVID-19 vaccine firms
16 May 2022 //
FIERCEPHARMA
Rapid Dose Tx and Skycare Compounding Labs to Provide Novel Oral Delivery
26 Apr 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Announces Management Change
10 Feb 2022 //
BUSINESSWIRE
Rapid Dose Therapeutics Appoints Dr. Michael Glogauer to Advisory Board
05 Jan 2022 //
BUSINESSWIRE
Rapid Dose, McMaster`s COVID Vaccine Study Bags NSERC R&D Grant
22 Dec 2021 //
BUSINESSWIRE
Rapid Dose Signs Product Supply Agreement with Oakland Health Limited
09 Dec 2021 //
BUSINESSWIRE
Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures
29 Nov 2021 //
BUSINESSWIRE
Rapid Completes Milestone 1M QuickStrip Units Shipped to a Single Company
24 Nov 2021 //
BUSINESSWIRE
Rapid Dose and McMaster University Provide COVID-19 Vaccine Research Update
15 Sep 2021 //
BUSINESSWIRE
Rapid Dose Therapeutics Reports Q1 Financial Results
25 Aug 2021 //
BUSINESSWIRE
